134 related articles for article (PubMed ID: 14999773)
1. Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines.
Muñoz J; Lázcoz P; Inda MM; Nistal M; Pestaña A; Encío IJ; Castresana JS
Int J Cancer; 2004 May; 109(5):673-9. PubMed ID: 14999773
[TBL] [Abstract][Full Text] [Related]
2. PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.
Inda MM; Mercapide J; Muñoz J; Coullin P; Danglot G; Tuñon T; Martínez-Peñuela JM; Rivera JM; Burgos JJ; Bernheim A; Castresana JS
Oncol Rep; 2004 Dec; 12(6):1341-7. PubMed ID: 15547761
[TBL] [Abstract][Full Text] [Related]
3. Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas.
Sanson M; Leuraud P; Aguirre-Cruz L; He J; Marie Y; Cartalat-Carel S; Mokhtari K; Duffau H; Delattre JY; Hoang-Xuan K
J Neurosurg; 2002 Dec; 97(6):1397-401. PubMed ID: 12507139
[TBL] [Abstract][Full Text] [Related]
4. PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas.
Fan X; Muñoz J; Sanko SG; Castresana JS
Int J Oncol; 2002 Sep; 21(3):667-74. PubMed ID: 12168116
[TBL] [Abstract][Full Text] [Related]
5. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
[TBL] [Abstract][Full Text] [Related]
6. Silencing of DMBT1 in neuroblastoma cell lines is not due to methylation of CCWGG motifs on its promoter.
Muñoz J; Castresana JS
Neoplasma; 2006; 53(1):15-8. PubMed ID: 16416007
[TBL] [Abstract][Full Text] [Related]
7. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.
Wu W; Kemp BL; Proctor ML; Gazdar AF; Minna JD; Hong WK; Mao L
Cancer Res; 1999 Apr; 59(8):1846-51. PubMed ID: 10213490
[TBL] [Abstract][Full Text] [Related]
8. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.
Lin H; Bondy ML; Langford LA; Hess KR; Delclos GL; Wu X; Chan W; Pershouse MA; Yung WK; Steck PA
Clin Cancer Res; 1998 Oct; 4(10):2447-54. PubMed ID: 9796977
[TBL] [Abstract][Full Text] [Related]
9. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.
Sasaki H; Zlatescu MC; Betensky RA; Ino Y; Cairncross JG; Louis DN
Am J Pathol; 2001 Jul; 159(1):359-67. PubMed ID: 11438483
[TBL] [Abstract][Full Text] [Related]
10. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
[TBL] [Abstract][Full Text] [Related]
11. Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer.
Sato K; Tamura G; Tsuchiya T; Endoh Y; Sakata K; Motoyama T; Usuba O; Kimura W; Terashima M; Nishizuka S; Zou T; Meltzer SJ
Virchows Arch; 2002 Feb; 440(2):160-165. PubMed ID: 11964046
[TBL] [Abstract][Full Text] [Related]
12. Expression of the DMBT1 gene is frequently suppressed in human lung cancer.
Takeshita H; Sato M; Shiwaku HO; Semba S; Sakurada A; Hoshi M; Hayashi Y; Tagawa Y; Ayabe H; Horii A
Jpn J Cancer Res; 1999 Sep; 90(9):903-8. PubMed ID: 10551316
[TBL] [Abstract][Full Text] [Related]
13. Analysis of PTEN/MMAC1 alteration in neuroblastoma.
Moritake H; Horii Y; Kuroda H; Sugimoto T
Cancer Genet Cytogenet; 2001 Mar; 125(2):151-5. PubMed ID: 11369059
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of DMBT1 gene expression in human oral squamous cell carcinoma.
Imai MA; Moriya T; Imai FL; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Tanzawa H
Int J Mol Med; 2005 Apr; 15(4):585-9. PubMed ID: 15754018
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors.
Pang JC; Dong Z; Zhang R; Liu Y; Zhou LF; Chan BW; Poon WS; Ng HK
Int J Cancer; 2003 May; 105(1):76-81. PubMed ID: 12672033
[TBL] [Abstract][Full Text] [Related]
16. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.
Marsit CJ; Zheng S; Aldape K; Hinds PW; Nelson HH; Wiencke JK; Kelsey KT
Hum Pathol; 2005 Jul; 36(7):768-76. PubMed ID: 16084946
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of the PTEN gene in ovarian cancer cell lines.
Schöndorf T; Ebert MP; Hoffmann J; Becker M; Moser N; Pur S; Göhring UJ; Weisshaar MP
Cancer Lett; 2004 Apr; 207(2):215-20. PubMed ID: 15072831
[TBL] [Abstract][Full Text] [Related]
18. Functional and molecular analyses of 10q deletions in human gliomas.
Steck PA; Lin H; Langford LA; Jasser SA; Koul D; Yung WK; Pershouse MA
Genes Chromosomes Cancer; 1999 Feb; 24(2):135-43. PubMed ID: 9885980
[TBL] [Abstract][Full Text] [Related]
19. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer.
Mollenhauer J; Herbertz S; Holmskov U; Tolnay M; Krebs I; Merlo A; Schrøder HD; Maier D; Breitling F; Wiemann S; Gröne HJ; Poustka A
Cancer Res; 2000 Mar; 60(6):1704-10. PubMed ID: 10749143
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity and microsatellite instability on chromosome arm 10q in neuroblastoma.
Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío IJ; Castresana JS
Cancer Genet Cytogenet; 2007 Apr; 174(1):1-8. PubMed ID: 17350460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
